City

Atlanta (1)

Chicago (1)

Indianapolis (1)

Kansas City (1)

Los Angeles (1)

Memphis (1)

New York (1)

Overall Status

Approved for marketing (1)

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Jazz Pharmaceuticals (1)

St. Jude Children's Research Hospital (1)

Collaborator

Intervention

cpx-351 (1)

miltenyi biotec clinimacs (1)

stem cell transplantation (1)

systemic chemotherapy and antibodies (1)

Study Documents

Intervention Type

drug (2)

device (1)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Expanded Access (1)

Interventional (1)

secondary aml

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Secondary AML Trial in United States (CPX-351)

Approved for marketing

Secondary AML

CPX-351

Los Angeles, California
+5 more

Aug 17, 2017

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Secondary AML Trial in Memphis (procedure, device, drug)

Completed

Acute Lymphoblastic Leukemia (ALL)
+9 more

Stem Cell Transplantation
+2 more

Memphis, Tennessee

St. Jude Children's Research Hospital

Feb 12, 2009